By Owen Tucker-Smith
Bruker projected fourth-quarter revenue ahead of the Wall Street consensus as the company continues to flex growth in the scientific instruments field.
The Massachusetts-based company said Monday it now expects fourth-quarter revenue of $970 million to $980 million. Analysts on Wall Street surveyed by FactSet had expected revenue of around $962.2 million. Bruker reported $854.5 million in revenue during the same period last year.
For the current year, Bruker expects revenue growth in the upper mid-single digits, excluding currency effects. The company has a goal of between 13% and 15% growth in adjusted earnings per share between 2025 and 2027.
Bruker issued the outlook ahead of a presentation at an industry conference. In a provided slide deck, it noted that China has been the major driver of growth over the last two decades, but the country's dominance moving forward is less clear.
In October, Bruker announced the launch of a new division, Bruker Spatial Biology, which aims to elevate industry technology with an array of spatial biology instruments, software and other services.
Shares were recently up 1.92% to $61.95 in Monday trading.
Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com
(END) Dow Jones Newswires
January 13, 2025 12:33 ET (17:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。